Brian R. Stanton

Array ( [id] => 4007742 [patent_doc_number] => 05859311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/534685 [patent_app_country] => US [patent_app_date] => 1995-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 8394 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859311.pdf [firstpage_image] =>[orig_patent_app_number] => 534685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866771 [patent_doc_number] => 05837534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Smooth muscle 22.alpha. promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 8/555723 [patent_app_country] => US [patent_app_date] => 1995-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9576 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837534.pdf [firstpage_image] =>[orig_patent_app_number] => 555723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3840220 [patent_doc_number] => 05847103 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Expression inhibitor comprising an antisense oligonucleotide derivative corresponding to human interleukin-6 receptor' [patent_app_type] => 1 [patent_app_number] => 8/549005 [patent_app_country] => US [patent_app_date] => 1995-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3157 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/847/05847103.pdf [firstpage_image] =>[orig_patent_app_number] => 549005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876472 [patent_doc_number] => 05763740 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Method of detecting prions in a sample and transgenic animal used for same' [patent_app_type] => 1 [patent_app_number] => 8/509261 [patent_app_country] => US [patent_app_date] => 1995-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 21631 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763740.pdf [firstpage_image] =>[orig_patent_app_number] => 509261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3653240 [patent_doc_number] => 05622698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Method and composition for increasing the supercooling point in invertebrates' [patent_app_type] => 1 [patent_app_number] => 8/499122 [patent_app_country] => US [patent_app_date] => 1995-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4442 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622698.pdf [firstpage_image] =>[orig_patent_app_number] => 499122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626096 [patent_doc_number] => 05686270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Production of antigens by self-assembly of polypeptide components' [patent_app_type] => 1 [patent_app_number] => 8/493112 [patent_app_country] => US [patent_app_date] => 1995-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 4523 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686270.pdf [firstpage_image] =>[orig_patent_app_number] => 493112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726153 [patent_doc_number] => 05670354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Use of VSV-G pseudotyped vectors for transfer of genes into embryos' [patent_app_type] => 1 [patent_app_number] => 8/480453 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 21520 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670354.pdf [firstpage_image] =>[orig_patent_app_number] => 480453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763810 [patent_doc_number] => 05849288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells' [patent_app_type] => 1 [patent_app_number] => 8/475584 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 26 [patent_no_of_words] => 18351 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849288.pdf [firstpage_image] =>[orig_patent_app_number] => 475584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659458 [patent_doc_number] => 05667777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Delivery of gene products via mesangial cells' [patent_app_type] => 1 [patent_app_number] => 8/480301 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6275 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/667/05667777.pdf [firstpage_image] =>[orig_patent_app_number] => 480301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805832 [patent_doc_number] => 05830878 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Cationic lipid: DNA complexes for gene targeting' [patent_app_type] => 1 [patent_app_number] => 8/485005 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 12192 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830878.pdf [firstpage_image] =>[orig_patent_app_number] => 485005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013877 [patent_doc_number] => 05880103 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Immunomodulatory peptides' [patent_app_type] => 1 [patent_app_number] => 8/488379 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 22898 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880103.pdf [firstpage_image] =>[orig_patent_app_number] => 488379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784696 [patent_doc_number] => 05736359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Isolated DNA molecules for integration site independent gene expression in mammalian host cells' [patent_app_type] => 1 [patent_app_number] => 8/478497 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 34 [patent_no_of_words] => 12208 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736359.pdf [firstpage_image] =>[orig_patent_app_number] => 478497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764654 [patent_doc_number] => 05849349 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Anti-cholesterolemic egg, vaccine and method for production, and use' [patent_app_type] => 1 [patent_app_number] => 8/478525 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6053 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849349.pdf [firstpage_image] =>[orig_patent_app_number] => 478525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045294 [patent_doc_number] => 05912236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Broad-spectrum tumor suppressor genes gene products and methods for tumor suppressor gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/470091 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 21904 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912236.pdf [firstpage_image] =>[orig_patent_app_number] => 470091 [rel_patent_id] =>[rel_patent_doc_number] =>)